Skip to main content

Sunshine Biopharma Inc.

SBFMW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001402328

No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $2.57K in total; no superinvestor holds it.

Other share classesSBFM

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +2 vs. previous quarter
3
13F valueReported value at the end of Q2 2026
$2.57K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding SBFMW, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding SBFMW at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Sunshine Biopharma Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 5, 2024 (view filing)4:05 PM ETMar 41 daySlilaty Steve N.Chief Executive OfficerPPurchaseSeries B Preferred Stock+100.0K$0.10+$10.0K+333.3%130.0K after
Feb 12, 2024 (view filing)4:05 PM ETFeb 84 daysSlilaty Steve N.Chief Executive OfficerPPurchaseSeries B Preferred Stock+20.0K$0.10+$2.00K+200.0%30.0K after
Dec 2, 2022 (view filing)Nov 302 daysSebaaly CamilleCFO/SecretaryPPurchase+30.0K$0.76+$22.8K+20.8%174.5K after
Jun 6, 2022 (view filing)Jun 33 daysSebaaly CamilleCFO/SecretaryPPurchase+25.0K$1.22+$30.5K+20.9%144.5K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Sunshine Biopharma Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 3 holders
Institutions holding SBFMW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
HRT Financial LP52,616$2.00K0.00%+52,616New
UBS Group AG11,879$5460.00%−12,000−50.3%Reduced
Clear Street Group Inc.449$270.00%+449New